Information about Immo-Pharm
My details
*
*
*

Immo-Pharm (SRL)

BE 0726.954.523

Place Saint-Pierre 29/1, 1040 Etterbeek

Company information

Status
Active

Enterprise number

BE0726.954.523

VAT liability
No
Established
21-05-2019
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Buying and selling of own real estate
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Immo-Pharm

2025 2024 2023 2022
Profit/Loss € 16,580 146,91% € 6,715 -58,84% € 16,313 43,26% € 11,387
Equity € 102,580 832,72% € -14,000 32,42% € -20,715 44,06% € -37,027
Gross margin € 37,985 52,75% € 24,868 -28,76% € 34,905 14,8% € 30,404

Publications from Immo-Pharm

Date Publication
17-03-2022 Registered Office - Resignations, Appointments (FR)
05-11-2020 Registered Office - Resignations, Appointments (FR)
23-05-2019 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the enterprise number of Immo-Pharm?
The enterprise number of Immo-Pharm is BE 0726.954.523.
Wat is the PEPPOL ID of Immo-Pharm?
The PEPPOL ID of Immo-Pharm is 0208:0726954523. Log in or start a free trial to see the full overview.
When was Immo-Pharm founded?
Immo-Pharm was founded on 21-05-2019.
What is the address of Immo-Pharm?
The current registered office of Immo-Pharm is located at Place Saint-Pierre 29/1, 1040 Etterbeek.
When was the last time Immo-Pharm filed their annual financial statements?
The most recent financial statements of Immo-Pharm were filed on 01-07-2026.
How many employees does Immo-Pharm have?
There are currently no employees working at Immo-Pharm or no workforce information is available.
What is the annual turnover of Immo-Pharm?
At the time of its most recent financial statements, Immo-Pharm did not publish any turnover figures. Immo-Pharm reported a gross margin of €37,985.20.

Sources